Your browser doesn't support javascript.
loading
Statin Use and Incidence of Parkinson's Disease in Women from the French E3N Cohort Study.
Nguyen, Thi Thu Ha; Fournier, Agnès; Courtois, Émeline; Artaud, Fanny; Escolano, Sylvie; Tubert-Bitter, Pascale; Boutron-Ruault, Marie-Christine; Degaey, Isabelle; Roze, Emmanuel; Canonico, Marianne; Ahmed, Ismaïl; Thiébaut, Anne C M; Elbaz, Alexis.
Afiliação
  • Nguyen TTH; Université Paris-Saclay, UVSQ, Univ. Paris-Sud, INSERM U1018, Team «Exposome, Heredity, Cancer and Health¼, CESP, Villejuif, France.
  • Fournier A; Université Paris-Saclay, UVSQ, Univ. Paris-Sud, INSERM U1018, Team «Exposome, Heredity, Cancer and Health¼, CESP, Villejuif, France.
  • Courtois É; Université Paris-Saclay, UVSQ, Univ. Paris-Sud, INSERM U1018, Team «High-Dimensional Biostatistics for Drug Safety and Genomics¼, CESP, Villejuif, France.
  • Artaud F; Université Paris-Saclay, UVSQ, Univ. Paris-Sud, INSERM U1018, Team «Exposome, Heredity, Cancer and Health¼, CESP, Villejuif, France.
  • Escolano S; Université Paris-Saclay, UVSQ, Univ. Paris-Sud, INSERM U1018, Team «High-Dimensional Biostatistics for Drug Safety and Genomics¼, CESP, Villejuif, France.
  • Tubert-Bitter P; Université Paris-Saclay, UVSQ, Univ. Paris-Sud, INSERM U1018, Team «High-Dimensional Biostatistics for Drug Safety and Genomics¼, CESP, Villejuif, France.
  • Boutron-Ruault MC; Université Paris-Saclay, UVSQ, Univ. Paris-Sud, INSERM U1018, Team «Exposome, Heredity, Cancer and Health¼, CESP, Villejuif, France.
  • Degaey I; Université Paris-Saclay, UVSQ, Univ. Paris-Sud, INSERM U1018, Team «Exposome, Heredity, Cancer and Health¼, CESP, Villejuif, France.
  • Roze E; Sorbonne Université, AP-HP, Département de Neurologie, Hôpital Pitié-Salpêtrière, Paris, France.
  • Canonico M; INSERM U1127, CNRS 7225, Team «Normal and Abnormal Motor Control: Movement Disorders and Experimental Therapeutics¼, Institut du Cerveau, Paris, France.
  • Ahmed I; Université Paris-Saclay, UVSQ, Univ. Paris-Sud, INSERM U1018, Team «Exposome, Heredity, Cancer and Health¼, CESP, Villejuif, France.
  • Thiébaut ACM; Université Paris-Saclay, UVSQ, Univ. Paris-Sud, INSERM U1018, Team «High-Dimensional Biostatistics for Drug Safety and Genomics¼, CESP, Villejuif, France.
  • Elbaz A; Université Paris-Saclay, UVSQ, Univ. Paris-Sud, INSERM U1018, Team «High-Dimensional Biostatistics for Drug Safety and Genomics¼, CESP, Villejuif, France.
Mov Disord ; 38(5): 854-865, 2023 05.
Article em En | MEDLINE | ID: mdl-36788159
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Inibidores de Hidroximetilglutaril-CoA Redutases Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Mov Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Inibidores de Hidroximetilglutaril-CoA Redutases Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Mov Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França